Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Julio Gallego-Delgado

Showing results (1-10 of 34) with videos related to

Pageof 4
Sort By:
Pathogens (Basel, Switzerland)|December 22, 2023
Pathology of Severe MalariaJulio Gallego-Delgado
Frontiers in Cellular and Infection Microbiology|February 27, 2024
Exploring adjunctive therapies for cerebral malariaJohanna Bensalel, Julio Gallego-Delgado
Trends in Parasitology|July 16, 2017
Rupture and Release: A Role for Soluble Erythrocyte Content in the Pathology of Cerebral MalariaJulio Gallego-Delgado, Ana Rodriguez
Circulation Research|September 24, 2016
The High Blood Pressure-Malaria Protection HypothesisJulio Gallego-Delgado, Thomas Walther, Ana Rodriguez
Seminars in Nephrology|May 15, 2025
Animal Models of Malaria-Associated Acute Kidney InjuryCollins Ojonugwa Mamudu, Rafael Polidoro, Julio Gallego-Delgado
Biorxiv : the Preprint Server for Biology|April 8, 2025
Cancer Drug Bortezomib, a Proteasomal Inhibitor, Triggers Cytotoxicity in Microvascular Endothelial Cells via Multi-Organelle StressPrajakta Sawant, Aleena Mathew, Johanna Bensalel, et al.
Frontiers in Immunology|June 8, 2026
Proteasomal inhibition compromises microvascular integrity via distinct effects on non-immune endothelial cells and immune cellsPrajakta Sawant, Hannah Wolf, Aleena Mathew, et al.
Pathogens (Basel, Switzerland)|June 24, 2022
Treatment Reducing Endothelial Activation Protects against Experimental Cerebral MalariaSabrina Mota, Johanna Bensalel, Do Hee Park, et al.
Current Rheumatology Reports|January 7, 2014
A surprising role for uric acid: the inflammatory malaria responseJulio Gallego-Delgado, Maureen Ty, Jamie M Orengo, et al.
Journal of Nephrology|December 19, 2006
Long-term treatment with an ACE inhibitor or an AT1 antagonist avoids hypertension-induced inflammation in the kidneyVanesa Esteban, Julio Gallego-Delgado, Alberto Lazaro, et al.
Pageof 4

Showing results (1-10 of 34) with videos related to

Sort By:
Pageof 4
Pathogens (Basel, Switzerland)|December 22, 2023
Pathology of Severe MalariaJulio Gallego-Delgado
Frontiers in Cellular and Infection Microbiology|February 27, 2024
Exploring adjunctive therapies for cerebral malariaJohanna Bensalel, Julio Gallego-Delgado
Trends in Parasitology|July 16, 2017
Rupture and Release: A Role for Soluble Erythrocyte Content in the Pathology of Cerebral MalariaJulio Gallego-Delgado, Ana Rodriguez
Circulation Research|September 24, 2016
The High Blood Pressure-Malaria Protection HypothesisJulio Gallego-Delgado, Thomas Walther, Ana Rodriguez
Seminars in Nephrology|May 15, 2025
Animal Models of Malaria-Associated Acute Kidney InjuryCollins Ojonugwa Mamudu, Rafael Polidoro, Julio Gallego-Delgado
Biorxiv : the Preprint Server for Biology|April 8, 2025
Cancer Drug Bortezomib, a Proteasomal Inhibitor, Triggers Cytotoxicity in Microvascular Endothelial Cells via Multi-Organelle StressPrajakta Sawant, Aleena Mathew, Johanna Bensalel, et al.
Frontiers in Immunology|June 8, 2026
Proteasomal inhibition compromises microvascular integrity via distinct effects on non-immune endothelial cells and immune cellsPrajakta Sawant, Hannah Wolf, Aleena Mathew, et al.
Pathogens (Basel, Switzerland)|June 24, 2022
Treatment Reducing Endothelial Activation Protects against Experimental Cerebral MalariaSabrina Mota, Johanna Bensalel, Do Hee Park, et al.
Current Rheumatology Reports|January 7, 2014
A surprising role for uric acid: the inflammatory malaria responseJulio Gallego-Delgado, Maureen Ty, Jamie M Orengo, et al.
Journal of Nephrology|December 19, 2006
Long-term treatment with an ACE inhibitor or an AT1 antagonist avoids hypertension-induced inflammation in the kidneyVanesa Esteban, Julio Gallego-Delgado, Alberto Lazaro, et al.
Pageof 4